From Xconomy Readers Set $20B Pricetag on Genzyme—Is That Too Rich for Sanofi-Aventis?:

Xconomy Survey, Genzyme
Xconomy Survey, Genzyme

Xconomy survey of Genzyme’s predicted buyout value.